M. Reza Sailani

M. Reza Sailani

Auto-generated profile, based on publicly available information

M. Reza Sailani

Department of Genetics, Stanford University, Stanford, CA, 94305, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSM. Reza Sailani
M. Reza Sailani
AMAhmed A. Metwally
Ahmed A. Metwally
WZWenyu Zhou
Wenyu Zhou
SRSophia Miryam Schüssler-Fiorenza Rose
Sophia Miryam Schüssler-Fiorenza Rose
SASara Ahadi
Sara Ahadi
MSMichael P Snyder
Michael P Snyder
The influence of seasons on biological processes is poorly understood. In order to identify biological seasonal patterns based on diverse molecular data, rather than calendar dates, we performed a deep longitudinal multiomics profiling of 105 individuals over 4 years. Here, we report more than 1000 seasonal variations in omics analytes and clinical measures. The different molecules group into two major seasonal patterns which correlate with peaks in late spring and late fall/early winter in California. The two patterns are enriched for molecules involved in human biological processes such as inflammation, immunity, cardiovascular health, as well as neurological and psychiatric conditions. Lastly, we identify molecules and microbes that demonstrate different seasonal patterns in insulin sensitive and insulin resistant individuals. The results of our study have important implications in healthcare and highlight the value of considering seasonality when assessing population wide health risk and management.

21 September 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MSM. Reza Sailani
M. Reza Sailani
fereshteh jahanbanifereshteh jahanbani
fereshteh jahanbani
CACharles W. Abbott
Charles W. Abbott
HLHayan Lee
Hayan Lee
AZAmin Zia
Amin Zia
MSMichael P Snyder
Michael P Snyder
Essential tremor (ET) is the most common adult-onset movement disorder. In the present study, we performed whole exome sequencing of a large ET-affected family (10 affected and 6 un-affected family members) and identified a TUB p.V431I variant (rs75594955) segregating in a manner consistent with autosomal-dominant inheritance. Subsequent targeted re-sequencing of TUB in 820 unrelated individuals with sporadic ET and 630 controls revealed significant enrichment of rare nonsynonymous TUB variants (e.g. rs75594955: p.V431I, rs1241709665: p.Ile20Phe, rs55648406: p.Arg49Gln) in the ET cohort (SKAT-O test p-value = 6.20e-08). TUB encodes a transcription factor predominantly expressed in neuronal cells and has been previously implicated in obesity. ChIP-seq analyses of the TUB transcription factor across different regions of the mouse brain revealed that TUB regulates the pathways responsible for neurotransmitter production as well thyroid hormone signaling. Together, these results support the association of rare variants in TUB with ET. Essential tremor (ET) is the most common adult-onset movement disorder and in most affected families it appears to be inherited in an autosomal dominant pattern. The causes of essential tremor are unknown. Although many genetic studies in affected families and sporadic cases of ET have shown that genes may play a role, it has proven quite challenging to identify the specific genetic variants involved. Here, we use state-of-the-art technologies to identify the role of genetic variants on ET through exome sequencing of a large affected ET family and subsequent validation in a large population of cases and controls. We show that rare nonsynonymous variants of the TUB gene are significantly enriched in ET cases versus healthy controls. Further studies of biological pathways regulated by TUB in the mouse brain reveal key pathways related to ET. Our work expands our knowledge of the genetic basis of ET.

18 June 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
SRShannon Rego
Shannon Rego
ODOrit Dagan-Rosenfeld
Orit Dagan-Rosenfeld
WZWenyu Zhou
Wenyu Zhou
MSM. Reza Sailani
M. Reza Sailani
PLPatricia Limcaoco
Patricia Limcaoco
MSMichael P Snyder
Michael P Snyder
Whole exome sequencing (WES) is increasingly utilized in both clinical and non-clinical settings, but little is known about the utility of WES in healthy individuals. In order to determine the frequency of both medically actionable and non-actionable but medically relevant exome findings in the general population we assessed the exomes of 70 participants who have been extensively characterized over the past several years as part of a longitudinal integrated multi-omics profiling study at Stanford University. We assessed exomes for rare likely pathogenic and pathogenic variants in genes associated with Mendelian disease in the Online Mendelian Inheritance in Man (OMIM) database. We used American College of Medical Genetics (ACMG) guidelines were used for the classification of rare sequence variants, and additionally we assessed pharmacogenetic variants. Twelve out of 70 (17%) participants had medically actionable findings in Mendelian disease genes, including 6 (9%) with mutations in genes not currently included in the ACMG’s list of 59 actionable genes. This number is higher than that reported in previous studies and suggests added benefit from utilizing expanded gene lists and manual curation to assess actionable findings. A total of 60 participants (89%) had non-actionable findings identified including 57 who were found to be mutation carriers for recessive diseases and 21 who have increased Alzheimer’s disease risk due to heterozyg ous or homozygous APOE e4 alleles (18 participants had both). These results suggest that exome sequencing may have considerably more utility for health management in the general population than previously thought.

2 December 2015 in Nature
Verified
Journal Article
Closed access
PDF file
ALAudrey Letourneau
Audrey Letourneau
FSFederico A. Santoni
Federico A. Santoni
XBXimena Bonilla
Ximena Bonilla
MSM. Reza Sailani
M. Reza Sailani
DGDavid Gonzalez
David Gonzalez
SAStylianos E. Antonarakis
Stylianos E. Antonarakis